The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: International Journal of Molecular Sciences 19.8 (2018).
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2018
- Urheber
-
Simon, Bianca
Wiesinger, Manuel
März, Johannes
Wistuba-Hamprecht, Kilian
Weide, Benjamin
Schuler-Thurner, Beatrice
Schuler, Gerold
Dörrie, Jan
Uslu, Ugur
- URN
-
urn:nbn:de:bvb:29-opus4-109602
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Simon, Bianca
- Wiesinger, Manuel
- März, Johannes
- Wistuba-Hamprecht, Kilian
- Weide, Benjamin
- Schuler-Thurner, Beatrice
- Schuler, Gerold
- Dörrie, Jan
- Uslu, Ugur
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2018
Ähnliche Objekte (12)
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Immunotherapy of malignant melanoma
Natural killer cell immunotherapy in glioblastoma
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Natural killer cells: a promising immunotherapy for cancer
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Beyond PD-1 Immunotherapy in Malignant Melanoma
Advances in predictive biomarkers for melanoma immunotherapy
The age of enlightenment in melanoma immunotherapy
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
New cell sources for CAR-based immunotherapy
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Immunotherapy of malignant melanoma
Natural killer cell immunotherapy in glioblastoma
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Natural killer cells: a promising immunotherapy for cancer
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Beyond PD-1 Immunotherapy in Malignant Melanoma
Advances in predictive biomarkers for melanoma immunotherapy
The age of enlightenment in melanoma immunotherapy
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
New cell sources for CAR-based immunotherapy
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma
Immunotherapy of malignant melanoma
Natural killer cell immunotherapy in glioblastoma
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Chimeric antigen receptor (CAR)-modified natural killer cell-based immunotherapy and immunological synapse formation in cancer and HIV
Natural killer cells: a promising immunotherapy for cancer
Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
Beyond PD-1 Immunotherapy in Malignant Melanoma
Advances in predictive biomarkers for melanoma immunotherapy
The age of enlightenment in melanoma immunotherapy
Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma